Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1428405

CNCCNC(=O)c1nc(Cl)c(N)nc1N.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCNN1A P37088 11/20 0.42
ALDH1A1 P00352 6/20 0.41
KDM4E B2RXH2 5/20 0.41
HPGD P15428 5/20 0.41
HSD17B10 Q99714 5/20 0.41
GLA P06280 4/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2D6 P10635 3/20 0.41
GAA P10253 3/20 0.41
NPC1 O15118 2/20 0.41
NFKB1 P19838 2/20 0.41
THPO P40225 2/20 0.41
HIF1A Q16665 2/20 0.41
FTO Q9C0B1 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CTSA P10619 2/20 0.41
RAB9A P51151 1/20 0.41
GMNN O75496 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1441745 0.92 SCNN1A (0.48) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL16541800 0.79 SCNN1A (0.53) SCNN1AALDH1A1KDM4EHPGDHSD17B10
Trifluoroacetic Acid SCHEMBL2290968 0.78 CNR1 (0.38) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL1429031 0.77 SCNN1A (0.50) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL10966794 0.75 SCNN1A (0.51) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL11959430 0.75 KCNH2 (0.48) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL1428063 0.75 MAPK1 (0.47) SCNN1AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL12379800 0.75 SCNN1A (0.60) SCNN1AALDH1A1KDM4EHPGDHSD17B10
Trifluoroacetic Acid SCHEMBL3527475 0.75 SCNN1A (0.43) SCNN1AALDH1A1KDM4EHPGDHSD17B10
Trifluoroacetic Acid SCHEMBL1134573 0.74 SCNN1A (0.40) SCNN1AALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110201625-A1 Organic Comopunds NOVARTIS AG (CH) 2011-08-18 US disclosed
EP-2300010-A2 ORGANIC COMPOUNDS Novartis AG (CH) 2011-03-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201625-A1 Organic Comopunds OR10J3, CFTR, CLIC1 SCNN1A 52/4885ALDH1A1 2244/4885KDM4E 3963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.